Phase I Study of Nimotuzumab in Combination With Simultaneous Chemotherapy and Radiation for Patients With Locally Advanced Esophageal Cancer.

Trial Profile

Phase I Study of Nimotuzumab in Combination With Simultaneous Chemotherapy and Radiation for Patients With Locally Advanced Esophageal Cancer.

Completed
Phase of Trial: Phase I

Latest Information Update: 24 Aug 2015

At a glance

  • Drugs Nimotuzumab (Primary) ; Cisplatin; Fluorouracil
  • Indications Oesophageal cancer
  • Focus Adverse reactions
  • Sponsors Biotech Pharmaceutical
  • Most Recent Events

    • 18 Aug 2015 Treatment arm Nimotuzumab + cisplatin + fluorouracil + radiotherapy has been replaced with Nimotuzumab.
    • 18 Aug 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 10 Aug 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top